Attending and mending the knowledge ecosystem

Search for:

KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)»Knowledge Ecology International

Menu Close

About
Areas of work
Coronavirus
Xtandi
Listserves
Videos
Publications
Databases
Donate

KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)

Posted on July 8, 2022 by James Love

This is a letter to Roche requesting a voluntary license to the patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA).

KEI-Risdiplan-patent-license-request-8july2022

Access to Medicine risdiplam, Roche, SMA, SMA Foundation

Human Rights Council heats up during informal talks on inequality, international solidarity, and intellectual property

WIPO General Assembly 2022: General statement of Knowledge Ecology International

KEI letter to Roche requesting voluntary license to patents on risdiplam, a treatment for Spinal Muscular Atrophy (SMA)

Meta

Categories